- Home
- VITL vs TRVI Comparison
VITL vs TRVI Comparison
Compare VITL & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VITL
- TRVI
- Stock Information
- Founded
- VITL 2007
- TRVI 2011
- Country
- VITL United States
- TRVI United States
- Employees
- VITL N/A
- TRVI N/A
- Industry
- VITL Packaged Foods
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- VITL Consumer Staples
- TRVI Health Care
- Exchange
- VITL Nasdaq
- TRVI Nasdaq
- Market Cap
- VITL 1.8B
- TRVI 1.4B
- IPO Year
- VITL 2020
- TRVI 2019
- Fundamental
- Price
- VITL $32.09
- TRVI $11.44
- Analyst Decision
- VITL Strong Buy
- TRVI Strong Buy
- Analyst Count
- VITL 9
- TRVI 10
- Target Price
- VITL $50.78
- TRVI $21.05
- AVG Volume (30 Days)
- VITL 1.5M
- TRVI 1.4M
- Earning Date
- VITL 11-04-2025
- TRVI 11-13-2025
- Dividend Yield
- VITL N/A
- TRVI N/A
- EPS Growth
- VITL 17.60
- TRVI N/A
- EPS
- VITL 1.32
- TRVI N/A
- Revenue
- VITL $711,881,000.00
- TRVI N/A
- Revenue This Year
- VITL $30.04
- TRVI N/A
- Revenue Next Year
- VITL $20.02
- TRVI N/A
- P/E Ratio
- VITL $24.35
- TRVI N/A
- Revenue Growth
- VITL 23.56
- TRVI N/A
- 52 Week Low
- VITL $28.00
- TRVI $2.36
- 52 Week High
- VITL $53.13
- TRVI $12.30
- Technical
- Relative Strength Index (RSI)
- VITL 33.48
- TRVI 58.81
- Support Level
- VITL $32.29
- TRVI $11.15
- Resistance Level
- VITL $34.20
- TRVI $12.30
- Average True Range (ATR)
- VITL 1.92
- TRVI 0.68
- MACD
- VITL -0.04
- TRVI -0.01
- Stochastic Oscillator
- VITL 11.94
- TRVI 58.41
About VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.